Vivodyne (Series A)

Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
May 30, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$40,000,000

Company Info
Traction
Already used by most top pharma companies, Vivodyne's platform significantly reduces trial risk and accelerates drug discovery.
Company Description
Vivodyne is rendering inaccurate animal testing obsolete, using automated robotic platforms and AI to grow and analyze thousands of fully functional human tissues. The company provides unprecedented, clinically relevant human data at massive scale, significantly reducing trial risk and accelerating drug discovery.
Market
Pharmaceuticals
Location
San Francisco, California, USA
Coinvestors
Lingotto Investment Management, Helena Capital, Fortius Ventures, Kairos Ventures, CS Ventures, Bison Ventures, MBX Capital

Links